英科医疗涨2.04%，成交额2.30亿元，主力资金净流入1590.98万元

Core Viewpoint - Inke Medical's stock price has shown significant growth this year, with a year-to-date increase of 64.94%, reflecting strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Inke Medical reported a revenue of 7.425 billion yuan, representing a year-on-year growth of 4.60% [2]. - The net profit attributable to shareholders for the same period was 924 million yuan, marking a substantial increase of 34.47% compared to the previous year [2]. Stock Market Activity - As of November 12, Inke Medical's stock price reached 41.45 yuan per share, with a trading volume of 230 million yuan and a market capitalization of 27.141 billion yuan [1]. - The stock experienced a net inflow of 15.9098 million yuan from institutional investors, indicating positive sentiment [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders for Inke Medical decreased by 21.11% to 47,300, while the average number of shares held per shareholder increased by 25.65% to 9,832 shares [2][4]. - The top circulating shareholders include various ETFs and mutual funds, with notable changes in holdings among major investors [4]. Dividend Distribution - Inke Medical has distributed a total of 1.903 billion yuan in dividends since its A-share listing, with 245 million yuan distributed over the past three years [3].